Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong
Taiwan FDA Increased Regulatory Fees
Published on: May 13th, 2021
The Taiwan FDA has announced a price increase for many regulatory items, with some seeing an increase as much as 163%. This notice went into effect on May 1, 2021 and is the 2nd time the TFDA has raised their fees in the last 6 months. Manufacturers of Class I products can expect to pay less than $600 for market access while new manufacturers with a Class III product will need to budget $6,000 for government fees.
For pricing details, please refer to the table below.
Item | Previous Fee | Current Fee (From May 1st) | % Change |
Class I Registration | NT$ 10,000
(US$ 357) |
NT$ 15,000
(US$ 536) |
50% |
Class II Registration | NT$ 25,000
(US$ 893) |
NT$ 58,000
(US$ 2,071) |
132% |
Class III Registration | NT$ 38,000
(US$ 1,357) |
NT$ 100,000
(US$ 3,571) |
163% |
QSD Registration/Renewal | NT$ 38,000
(US$ 1,357) |
NT$ 60,000
(US$ 2,143) |
58% |
Indication Change | NT$ 30,000
(US$ 1,071) |
NT$ 40,000
(US$ 1,429) |
33% |
Specification Change (with impact on performance & safety) | NT$ 25,000
(US$ 893) |
NT$ 35,000
(US$ 1,250) |
40% |
Specification Change (without impact on performance & safety) | NT$ 15,000
(US$ 536) |
NT$ 25,000
(US$ 893) |
67% |
Model Addition | NT$ 25,000
(US$ 893) |
NT$ 35,000
(US$ 1,250) |
40% |
Manufacturing Site Change | NT$ 15,000
(US$ 536) |
NT$ 25,000
(US$ 893) |
67% |
Device Registration Transfer | NT$ 15,000
(US$ 536) |
NT$ 25,000
(US$ 893) |
67% |
QSD Registration Transfer | NT$ 8,000
(US$ 286) |
NT$ 10,000
(US$ 357) |
25% |
Device Renewal | NT$ 6,000
(US$ 214) |
NT$ 8,000
(US$ 286) |
33% |
Copy of Device Certificate | NT$ 1,500
(US$ 54) |
NT$ 1,500
(US$ 54) |
0% |
Registration Process Overview in Taiwan
In Taiwan, medical device registration is overseen by the Taiwan Food and Drug Administration (Taiwan FDA), a division of the Ministry of Health and Welfare. Class I devices will go through an Administrative Review, and Class II, III, and New devices (no predicates) will go through both an Administrative and Technical Review, as well as a Quality System Document (QSD) Review. While fees have increased in Taiwan, the review fees are still relatively affordable compared to other markets in the region.
Once issued, licenses are valid for 5 years. Licenses in Taiwan are transferrable and will need to be completed by both the transferor and the transferee jointly. To learn more about the regulatory process in Taiwan, please click here.
Expedited Market Access For US/EU Approved Devices
Clinical data is only required for Class III IVDs and New products. Class II medical devices with approval in the US or EU can usually use existing documentation in place of the preclinical test, quality control procedure and test reports.
Grow with Us
Asia Actual is available to help navigate the medical device registration requirements and regulatory pathway for medical device and IVDs in Taiwan.
Contact Asia Actual for more information discussing the potential for your medical device or IVD in the Taiwanese market.